AlphaHelix provides the means to detect and quantify pathogens, identify people, improve gene analysis and genomic research. AlphaHelix defines platform sensitivity: See the definition for Scope for Detection.

A new platform for molecular diagnostics and research applications. AlphaHelix instrument platform is based on the proprietary technology SuperConvection™. It enables qPCR in 10 minutes, sequence verified DNA-detection in 90 minutes.

The first superconvector instrument from AlphaHelix has a capacity of 48 individual 0.2 mL microtubes and features real-time detection and HRM capability. Superconvection gives instantaneous and homogenous thermal equilibration, cutting thermocycling times to seconds.

Come and meet us and see our new instrument at Advances in qPCR in Stockholm, Sweden, Sept 17-18, 2008.

2008-06-10
Förändringar av organisationen och besparingar

2008-06-05
Kommuniké från AlphaHelix årsstämma

2008-05-22
Delårsrapport jan-mars 2008

Pressmeddelande 2008-05-13
Konkurrent erbjuder snabbt testkit för Johne´s disease

Pressmeddelande 2008-05-09
Årsredovisningen för 2007 finns nu tillgänglig på hemsidan (Direktlänk till Årsredovisning 2007.)

2008-05-07
Kallelse till årsstämma onsdagen den 4 juni 2008

2008-04-25
Framgång i blindtestet av Johne´s disease

QuanTyper-48
QuanTyper-48
 
                     The PCR process is covered by several patents owned by Roche Molecular Systems and F.Hoffman-La Roche Limited.